Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | USP2 | O75604 | 1/20 | 0.42 |
| ▸ | HDAC8 | Q9BY41 | 5/20 | 0.41 |
| ▸ | ACHE | P22303 | 2/20 | 0.38 |
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
| ▸ | HRH1 | P35367 | 1/20 | 0.38 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.38 |
| ▸ | CA2 | P00918 | 1/20 | 0.38 |
| ▸ | CA4 | P22748 | 1/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.34 |
| ▸ | HPGD | P15428 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.34 |
| ▸ | RAB9A | P51151 | 2/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
| ▸ | SLC2A1 | P11166 | 1/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
| ▸ | RCE1 | Q9Y256 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL27831 | 0.98 | USP2 (0.41) | USP2HDAC8ACHETSHRHRH1 | |
| Hydrochloric Acid SCHEMBL31124474 | 0.98 | USP2 (0.41) | USP2HDAC8ACHETSHRHRH1 | |
| Acetic Acid SCHEMBL149422 | 0.83 | HDAC8 (0.43) | USP2HDAC8ACHETSHRHRH1 | |
| SCHEMBL29922 | 0.80 | HDAC8 (0.48) | HDAC8ACHETSHRHRH1PDE4D | |
| SCHEMBL13113036 | 0.80 | HDAC8 (0.43) | HDAC8ACHETSHRHRH1PDE4D | |
| Hydrochloric Acid SCHEMBL11768005 | 0.78 | HDAC8 (0.41) | HDAC8ACHETSHRHRH1PDE4D | |
| Hydrochloric Acid SCHEMBL150596 | 0.78 | HDAC8 (0.46) | HDAC8ACHETSHRHRH1PDE4D | |
| SCHEMBL546287 | 0.78 | NNMT (0.42) | HDAC8ACHETSHRHRH1PDE4D | |
| SCHEMBL15822329 | 0.78 | HDAC8 (0.46) | HDAC8ACHETSHRHRH1PDE4D | |
| Hydrochloric Acid SCHEMBL28336457 | 0.78 | HDAC8 (0.41) | HDAC8ACHETSHRHRH1PDE4D |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 451 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260015574-A1 | METHODS FOR SHORTENING LAG PHASE DURATION IN MICROORGANISMS | YEDA RES & DEV (IL) | 2026-01-15 | — | — | US | claimed |
| EP-4479512-A1 | METHODS FOR SHORTENING LAG PHASE DURATION IN MICROORGANISMS | Yeda Research and Development Co. Ltd (IL) | 2024-12-25 | — | — | EP | claimed |
| WO-2024180161-A1 | MULTICOMPONENT DEEP EUTECTIC SOLVENTS, THEIR PREPARATION AND USE | VIO INVENT PRIVATE COMPANY (GR) | 2024-09-06 | — | — | WO | claimed |
| WO-2023157003-A1 | METHODS FOR SHORTENING LAG PHASE DURATION IN MICROORGANISMS | YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) | 2023-08-24 | — | — | WO | claimed |
| EP-3256102-B1 | PEPTIDIC COMPOUNDS, COMPOSITIONS COMPRISING THEM AND USES OF SAID COMPOUNDS, IN PARTICULAR COSMETIC USES | SEDERMA SA (FR) | 2023-08-09 | — | — | EP | claimed |
| US-20230101362-A1 | RNA STABILIZATION | TEAM MEDICAL LLC | 2023-03-30 | — | — | US | claimed |
| US-11612556-B2 | Peptidic compounds, compositions comprising them and uses of said compounds, in particular cosmetic uses | SEDERMA (FR) | 2023-03-28 | — | — | US | claimed |
| US-20220305401-A1 | EUTECTIC EXTRACTION OF SOLIDS | GIVAUDAN SA (CH) | 2022-09-29 | — | — | US | claimed |
| EP-3986160-A1 | EUTECTIC EXTRACTION OF SOLIDS | Givaudan SA (CH) | 2022-04-27 | — | — | EP | claimed |
| US-11020438-B2 | Phospholipid compositions and their preparation | AKER BIOMARINE ANTARCTIC AS (NO) | 2021-06-01 | — | — | US | claimed |
| CN-104549961-A | Ship anti-pollution method | QINGDAO WUWEI THERMAL INSULATION MAT CO LTD | 2015-04-29 | — | — | CN | claimed |
| EP-2784189-A1 | Electroplating bath for zinc-iron alloys, method for depositing zinc-iron alloy on a device and such a device | Coventya SAS (FR) | 2014-10-01 | — | — | EP | claimed |
| US-8388939-B2 | Moisturizing cosmetic composition comprising a combination of homarine and erythritol | SEDERMA, S.A.S. (FR) | 2013-03-05 | — | — | US | claimed |
| EP-2252375-B1 | Moisturizing cosmetic composition comprising a combination of homarine and erythritol | SEDERMA SA (FR) | 2012-08-08 | — | — | EP | claimed |
| US-20110002865-A1 | MOISTURIZING COSMETIC COMPOSITION COMPRISING A COMBINATION OF HOMARINE AND ERYTHRITOL | SEDERMA, S.A.S. (FR) | 2011-01-06 | — | — | US | claimed |
| EP-2252375-A1 | MOISTURIZING COSMETIC COMPOSITION COMPRISING A COMBINATION OF HOMARINE AND ERYTHRITOL | Sederma (FR) | 2010-11-24 | — | — | EP | claimed |
| WO-2009104118-A1 | MOISTURIZING COSMETIC COMPOSITION COMPRISING A COMBINATION OF HOMARINE AND ERYTHRITOL | SEDERMA (FR) | 2009-08-27 | — | — | WO | claimed |
| WO-2008044099-A1 | CHARGE TRANSFER COMPLEXES IN THE TREATMENT OF INFLAMMATORY BOWEL DISEASES | GHISALBERTI CARLO (BR) | 2008-04-17 | — | — | WO | claimed |
| WO-2004035818-A1 | USE OF OSMOLYTES TO HEAT STABILISE LUCIFERASE AND/OR APYRASE | BIOTAGE AB (SE) | 2004-04-29 | — | — | WO | claimed |
| US-5622944-A | MODIFIED 17-HYDROXY STEROL; TRANSDERMAL ELECTROTRANSPORT ENHANCEMENT | AFFYMAX TECHNOLOGIES N.V. (GB) | 1997-04-22 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11612556-B2 | Peptidic compounds, compositions comprising them and uses of said compounds, in particular cosmetic uses | PLOD1, COL1A1, PLOD2 | USP2 3363/4885HDAC8 1234/4885ACHE 2530/4885 |
| US-20110002865-A1 | MOISTURIZING COSMETIC COMPOSITION COMPRISING A COMBINATION OF HOMARINE AND ERYTHRITOL | AQP1, CUTA, AQP3 | USP2 2678/4885HDAC8 3696/4885ACHE 1103/4885 |
| US-11020438-B2 | Phospholipid compositions and their preparation | PHOSPHO1, PLTP, PLIN5 | USP2 3939/4885HDAC8 1694/4885ACHE 1513/4885 |
| US-20260015574-A1 | METHODS FOR SHORTENING LAG PHASE DURATION IN MICROORGANISMS | DNMT3A, DNMT3L, FBL | USP2 3109/4885HDAC8 4305/4885ACHE 1207/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.